The biotechnology company discovers and manufactures treatments for neurological and neurodegenerative diseases. It has recently garnered attention for its experimental Alzheimer’s drug, aducanumab.
Courtesy of Biogen
Lists ranking Biogen
Latest news for Biogen
- NewslettersWhy the FDA’s ruling on mixing and matching vaccines will help more people get boostersOctober 21, 2021 8:18 PM UTC
- NewslettersThe stalemate over patents is fueling vaccine inequity—and the pandemicOctober 14, 2021 8:05 PM UTC
- NewslettersWhy Merck’s antiviral pill is not a silver bullet for COVIDOctober 7, 2021 8:07 PM UTC
- NewslettersWill vaccine mandates worsen the ongoing health care shortage?September 30, 2021 8:23 PM UTC